Rotavirus Vaccine

Table of contents

  • Brand Names
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Drug Interactions
  • Dosage

Brand Names


Austria: Rotarix, RotaTeq; Belgium: Rotarix, RotaTeq; Bulgaria: Rotarix, RotaTeq; Cyprus: Rotarix, RotaTeq; Czech Republic: Rotarix, RotaTeq; Denmark: Rotarix, RotaTeq; Estonia: Rotarix, RotaTeq; Finland: Rotarix, RotaTeq; France: Rotarix, RotaTeq; Germany: Rotarix, RotaTeq; Hungary: Rotarix, RotaTeq; Ireland: Rotarix, RotaTeq; Italy: Rotarix, RotaTeq; Latvia: Rotarix, RotaTeq; Lithuania: Rotarix, RotaTeq; Luxembourg: Rotarix, RotaTeq; Malta: Rotarix, RotaTeq; Netherlands: Rotarix; Poland: Rotarix, RotaTeq; Portugal: Rotarix, RotaTeq; Romania: Rotarix, RotaTeq; Slovakia: Rotarix, RotaTeq; Slovenia: Rotarix, RotaTeq; Spain: RotaTeq; Sweden: RotaTeq; UK: Rotarix.

North America

Canada: Rotarix, RotaTeq; USA: Rotarix, RotaTeq.

Latin America

Argentina: Rotarix, RotaTeq; Brazil: Vacina Contra Rotavirus; Mexico: Rotarix.

Drug combinations


Pharmacologic Category

Serums, Toxoids, and Vaccines; Vaccines. Live Viral Vaccine. (ATC-Code: J07BH01/2).

Mechanism of action

Replicates in small intestine and promotes active immunity to rotavirus gastroenteritis.

Therapeutic use

Prevention of rotavirus gastroenteritis in infants and children.

Pregnancy and lactiation implications

Not indicated for use in women of reproductive age. Infants living in households with pregnant women may be vaccinated. Infants receiving vaccine may be breast-fed.

Unlabeled use


Hypersensitivity to rotavirus vaccine or any component of the formulation. Contraindicated with history of uncorrected congenital malformation of GI tract.

Warnings and precautions

Anaphylactoid and/or hypersensitivity reactions might occur. Use caution with history of intussusception. May be administered in mild acute illness (with or without fever). Use with caution in infants with history of GI disorders, acute GI illness, chronic diarrhea, failure to thrive, congenital abdominal disorders, abdominal surgery, and intussusception. Vaccine may be used with controlled gastroesophageal reflux disease. Consider delaying administration to infants with acute diarrhea or vomiting. Oral suspension contraindicated with history of uncorrected congenital malformation of GI tract. Use with caution in presence of immunocompromised family members.



Legal Notice
Privacy Policy
Cookie Policy


Phone: +34-981-780505
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart